Skip to content
Search
Generic filters
API Products
API Sourcing
Strategic Sourcing
505(b)(2) Pathway
Regulatory Support
Logistics
Manufacturer Management Program
CDMO Services
Formulation Development
Solid Dose Delivery Systems
Liquids / Suspensions
Semi-Solids
Suppositories
Commercial Scale-Up Facilities & Equipment
Regulatory Management
Analytical Services
Analytical Testing
Stability Services
Analytical Testing Services for Compounders
Analytical Testing for Manufacturers
Resources
About LGM
Quality Commitment
Leadership
Company History
Clients
News
Events
Careers
Blog
Contact Us
API Products
API Sourcing
Strategic Sourcing
505(b)(2) Pathway
Regulatory Support
Logistics
Manufacturer Management Program
CDMO Services
Formulation Development
Solid Dose Delivery Systems
Liquids / Suspensions
Semi-Solids
Suppositories
Commercial Scale-Up Facilities & Equipment
Regulatory Management
Analytical Services
Analytical Testing
Stability Services
Analytical Testing Services for Compounders
Analytical Testing for Manufacturers
Resources
About LGM
Quality Commitment
Leadership
Company History
Clients
News
Events
Careers
Blog
Contact Us
News
The Latest News from LGM Pharma
LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites
March 19, 2026
— $9M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased...
LGM Pharma Invests $6M in U.S. Drug Manufacturing Capabilities for Liquids, Suspensions, Semi-Solids, and Suppositories
March 12, 2025
LGM Pharma Invests $6M in U.S. Drug Manufacturing Capabilities for Liquids, Suspensions, Semi-Solids,...
N-Zyme Biomedical and LGM Pharma are Developing the World’s First Pepsin Inhibitor for Reflux Disease
November 18, 2024
N-Zyme Biomedical and LGM Pharma are Developing the World’s First Pepsin Inhibitor for Reflux Disease...
New Harbor Capital Portfolio Company LGM Pharma Promotes CFO and CCO
October 22, 2024
October 22, 2024 – Chicago, IL – New Harbor Capital (“New Harbor”) is excited to announce that portfolio...
LGM Pharma Expands Analytical Testing Services with New Endotoxin and Rapid Sterility Testing Capabilities
October 15, 2024
—New Capabilities and State-of-the-Art Equipment at Irvine Facility Accelerates Turnaround Time and Enhances...
New Harbor Capital Completes Recapitalization of Portfolio Company LGM Pharma to Support Its Continued Growth
October 01, 2024
Chicago, IL and Boca Raton, FL, New Harbor Capital (“New Harbor”) announced today the recapitalization,...
1
2
3
Next
How can we help?
Contact Us
